Keyphrases
Prostate Cancer
87%
Asia
36%
Prostate Cancer Patients
28%
Benign Prostatic Hyperplasia
26%
Indonesia
24%
Prostate-specific Antigen
24%
Indonesian
24%
E-cadherin
20%
Tumor
17%
Asian Countries
17%
Prostate Volume
16%
Jakarta
16%
Bladder Cancer
13%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
13%
Hormone Therapy
13%
Prostate-specific Antigen Level
12%
Overall Survival
11%
Risk Factors
10%
Oncology
10%
Patients with Prostate Cancer
10%
Androgen Deprivation Therapy
10%
E-cadherin Expression
10%
Meta-analysis
9%
Metastasis
9%
Transitional Cell Carcinoma
8%
Prostate Radiotherapy
8%
Prostate Biopsy
7%
Prostate Cancer Risk
7%
Bladder
7%
Lycopene
7%
Japan
7%
Prostate Carcinoma
7%
Renal Cell Carcinoma
7%
Muscle-invasive Bladder Cancer
7%
Urology
7%
Immunoreactivity
7%
Bladder Tumor
7%
Prostate Cancer Screening
7%
Retrospective Analysis
6%
Progressivity
6%
Advanced Prostate Cancer
6%
Prostate
6%
Cancer Study
6%
Upper Tract Urothelial Carcinoma
6%
Bone Scan
6%
Human Prostate Cancer Cells
6%
Prostate Disease
6%
Gleason Score
6%
COVID-19
6%
Stadium
6%
Medicine and Dentistry
Prostate Cancer
100%
Prostate Hypertrophy
23%
Transitional Cell Carcinoma
19%
Prostate Specific Antigen
19%
Malignant Neoplasm
18%
Metastatic Carcinoma
16%
Biopsy
14%
Neoplasm
13%
Bladder
11%
Oncology
11%
Clear Cell Renal Cell Carcinoma
10%
Cancer Hormone Therapy
9%
Disease
9%
Transrectal Ultrasonography
9%
Prostatectomy
9%
Bladder Cancer
8%
Overall Survival
8%
Prostate Biopsy
8%
Prostate Carcinoma
7%
Urology
7%
Androgen Deprivation Therapy
7%
Somatomedin
6%
Predictive Factor
6%
COVID-19
6%
Prostate Disease
6%
Cancer Control
6%
Surgery
5%
Urologist
5%